Imagen de Portada

Dosimetric effectiveness in implants with distinct Ho-166 seed distributions in a prostate model

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Viviane Vitória Bento Braga
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Sociedade Brasileira de Proteção Radiológica - SBPR 2019
Materias:	Biología Ho 166 seeds brachytherapy Prostate cancer
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

First experience of salvage HDR brachytherapy after prostate cancer radiotherapy
por: Juras Kišonas
Publicado: (2014)

What are the outcomes and effectiveness of high-dose-rate (HDR) brachytherapy in the treatment of rectal cancer?
por: Tripdatabase
Publicado: (2026)

Comparative antiproliferation of human prostate cancer cells by ethanolic extracts of two groups of Brazilian propolis
por: Cleber Silveira MORAES
Publicado: (2010)

Journal of Contemporary Brachytherapy
Publicado: (2016)

Separation of Micro-Macrocomponent Systems: 149Pm – Nd, 161Tb-Gd, 166Ho-Dy and 177Lu-Yb by Extraction Chromatography
por: F. Monroy-Guzman
Publicado: (2015)

Incidence of adenocarcinoma in the transitional zone of the prostate in a public institution. Cochabamba, Bolivia
por: Javier Ferrufino Iriarte
Publicado: (2020)

Changes in prostate cancer incidence in 50–75-year-old men in Lithuania 2006–2009: effect of early diagnosis program
por: Robertas Adomaitis
Publicado: (2011)

Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
por: Vladimir Zaichick
Publicado: (2020)

AI-Driven Multi-Targeted Phytochemical Formulation for Prostate Cancer Prevention and Support: A Theoretical Framework for Research
por: Landry, Marie Seshat
Publicado: (2025)

Quality Control for Cervical Ca treatments on HDR Brachytherapy with Ir-192
por: G. Alvarino Bettín
Publicado: (2013)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Paulius Aliukonis
Publicado: (2017)

The first clinical experience in prostate cancer salvage cryotherapy
por: Ulys Albertas
Publicado: (2013)

¿ Existe el cáncer localizado de próstata?
por: Bernard LOBEL MANDEL
Publicado: (2005)

Oncological outcomes of surgery in very high risk pT3b prostate cancer
por: Daimantas Milonas
Publicado: (2011)

Molecular analysis of multifocal prostate cancer cases
por: Rasa Sabaliauskaitė
Publicado: (2011)

Prostate cancer patient’s survival in Lithuania
por: Giedrė Smailytė
Publicado: (2012)

Quality control of the breast ca treatments on HDR brachytherapy with TLD-100
por: F. Torres Hoyos
Publicado: (2014)

Cáncer de Próstata. ¿Qué es el antígeno prostático específico?. (La biología del PSA)
por: Juan Fernando Uribe Arcila
Publicado: (2007)

Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells.
por: Leo Turner
Publicado: (2021)

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO.
por: Willisch P, et al.
Publicado: (2026)

Prostate-specific antigen in men from the municipality of Paipa, Boyacá 2016
por: Angela Liliana Monroy Díaz
Publicado: (2018)

Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013
por: Luisa E Torres-Sánchez
Publicado: (2016)

Aspects of an automatic system of implants of radioactive seeds and anatomic object simulator for tests in prostate brachytherapy
por: Leonardo Santiago Melgaço Silva
Publicado: (2019)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
por: Kamil Malshy, et al.
Publicado: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
por: Eric V. Li, et al.
Publicado: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
por: Shingo Ashida, et al.
Publicado: (2024)

Cuestionario en línea para el estudio de Postcomercialización del Prevengho® Vir utilizado contra la COVID-19
por: Nancy Burguet Lago
Publicado: (2021)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
por: YuNing Zhang, et al.
Publicado: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
por: Zain Abedali, et al.
Publicado: (2024)

THE MEANING OF TOUCH THE PROSTATE FOR MAN: THE NURSE IN HEALTH PROMOTION
por: Taiane Bertoldi da Costa
Publicado: (2013)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
por: Pengfei Zhang, et al.
Publicado: (2024)

Diagnosis and management of neuroendocrine prostate cancer
por: Ivan de Kouchkovsky, et al.
Publicado: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
por: Naz Chaudary, et al.
Publicado: (2024)

Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation
por: Taro Igarashi, et al.
Publicado: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
por: Reyhane Karegar‐Niavol, et al.
Publicado: (2024)

Responses to queries concerning “Performance of large language models on benign prostatic hyperplasia frequently asked questions”
por: YuNing Zhang, et al.
Publicado: (2024)

Other‐cause mortality in incidental prostate cancer
por: Francesco Di Bello, et al.
Publicado: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
por: Pranav Prakash, et al.
Publicado: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
por: Yirui Wei, et al.
Publicado: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
por: Tianwei Jia, et al.
Publicado: (2024)